Antiretroviral News and Research

RSS

HIV/AIDS drugs may also be effective against malaria

Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.

2 Jun 2005

HIV deaths drop 90 percent among African-American IDUs who are given access to combination drug therapy

Combination drug therapy effectively reduces 90 percent of HIV deaths in African-American injection drug users when they are given ample access to care, according to a new Academy study in the June issue of the American Journal of Epidemiology.

1 Jun 2005

Clinton Foundation aims to treat two million people with HIV in India by 2008

Former United States President Bill Clinton announced in India this week that his Foundation plans to train 150,000 private sector doctors for care and treatment.

26 May 2005

Immediate treatment after suspected HIV transmission may do more harm than good

The active promotion of immediate treatment after suspected HIV transmission to minimise the risk of infection may be doing more harm than good, claim senior doctors in Sexually Transmitted Infections.

25 May 2005

Guyana Health Minister outlines progress at World Health Assembly

Guyana Health Minister Dr. Leslie Ramsammy has outlined health progress being made in his country despite high levels of poverty and major floods that affected hundreds of thousands of people earlier this year.

23 May 2005

FDA recommends approval of the investigational anti-HIV drug tipranavir

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee recommended the approval of the investigational anti-HIV drug tipranavir (11-3). Tipranavir is a non-peptidic protease inhibitor that requires boosting with low-dose ritonavir and must be used in combination with other antiretroviral agents.

20 May 2005

World Bank and IMF preventing transfer of foreign aid to HIV/AIDS programmes

Multilateral financial organisations that aim to reduce poverty are preventing foreign aid from reaching HIV/AIDS programs in developing countries, states an article in this week’s issue of The Lancet.

19 May 2005

Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active anti-retroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.

18 May 2005

Roche to discontinue the sale and distribution of Fortovase (saquinavir)

Roche announced today that it has decided to discontinue the sale and distribution of Fortovase (saquinavir), as clinical demand for the drug has declined significantly due to the availability of a new formulation of Invirase (saquinavir mesylate), which increasingly has become the preferred formulation of saquinavir.

18 May 2005

Asymptomatic HIV-infected newborns may benefit from early drug treatment

Identifying and treating HIV-infected newborns is a race against the clock, according to a study from the Stanford University School of Medicine and Lucile Packard Children's Hospital.

10 May 2005

Squeeze of lemon and raw garlic all you need to fight AIDS!!!!

South Africa's health minister insisted last week that her government would not be pressured into meeting U.N. treatment targets.

8 May 2005

WHO’s goal to provide life-long antiretroviral therapy to 3 million people with HIV/AIDS at risk of failing

Lack of financial resources, staff, and commitment from key countries, may hamper WHO’s goal to provide life-long antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005 (3 by 5), states an editorial in this week’s issue of The Lancet.

4 May 2005

HIV treatment not affected by hormonal birth control

Estrogen and progesterone hormones in birth control do not influence the effectiveness of highly active antiretroviral therapy (HAART), which is used to treat HIV infection, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions. The study is published in the May 1, 2005, issue of the American Journal of Epidemiology.

2 May 2005

Antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system

By studying animals, Johns Hopkins researchers have discovered that the antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system, problems that can develop even though antiretroviral therapy controls the virus elsewhere in the body.

1 May 2005

New guidelines for managing chronic kidney disease in patients living with HIV infection

The HIV Medicine Association has released guidelines for managing chronic kidney disease in patients living with HIV infection. They are published in the June 1 issue of Clinical Infectious Diseases.

27 Apr 2005

Wide variation in access to HIV medications across states

Twenty-one State AIDS Drug Assistance Programs (ADAPs) report limiting access to their programs in some way, including 11 with waiting lists, despite an increase in the national ADAP budget, according to the ninth annual National ADAP Monitoring Project Report released by the Kaiser Family Foundation and the National Alliance of State AIDS Directors (NASTAD).

23 Apr 2005

Call for a United States Global Health Service

The federal government should create and fund an umbrella organization called the United States Global Health Service (GHS) to mobilize the nation's best health care professionals and other experts to help combat HIV/AIDS in hard-hit African, Caribbean, and Southeast Asian countries, says a new report from the Institute of Medicine of the National Academies.

19 Apr 2005